We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Biomarker Discovered for Pregnancy-Related Heart Disease

By LabMedica International staff writers
Posted on 16 May 2013
A molecule has been identified that can serve as a biomarker for peripartum cardiomyopathy that occurs in pregnant women during the last month or in the months following their pregnancy.

The molecule is a micro-ribonucleic acid (miRNA) which is induced by the nursing hormone prolactin and detection in the blood, protected from endogenous ribonuclease (RNase) activity by exosomes, has emerged as a promising diagnostic tool.

Scientists at the University of Liege (Belgium) obtained plasma samples from 38 patients with peripartum cardiomyopathy (PPCM) at their first presentation and from18 healthy nursing women, from five age-matched healthy controls, from 30 patients with heart failure due to dilated cardiomyopathy (DCM), and from patients with PPCM receiving bromocriptine. More...


The investigators found the expression miRNA miR-146a was induced by the nursing hormone prolactin. MiR-146a expression promoted vascular damage and was increased in a mouse model of PPCM. Conversely, loss of miR-146a in mice prevented PPCM. Plasma levels of miR-146a were significantly higher in patients with acute PPCM compared with healthy postpartum controls. Levels of miR-146a were not significantly different between healthy postpartum controls and healthy nonpregnant women. Compared with 30 patients with a similar degree of heart failure due to DCM and with no history of PPCM, miR-146a levels were significantly higher in the PPCM group.

The results of this study indicate that miR-146a mediates antiangiogenic effects of 16-kDa N-terminal prolactin fragment (16K PRL) in endothelial cells and the slowing of metabolism in cardiomyocytes. In addition, this microRNA may serve as a highly specific blood biomarker useful for diagnosis and risk stratification of patients with peripartum heart failure and appears to be a specific biomarker of PPCM. The study was published on April 24, 2013, in the Journal of Clinical Investigation.

Related Links:

University of Liege




Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: Determining EG spiked into medicinal syrups: Zoomed-in images of the pads on the strips are shown. The red boxes show where the blue color on the pad could be seen when visually observed (Arman, B.Y., Legge, I., Walsby-Tickle, J. et al. https://doi.org/10.1038/s41598-025-26670-1)

Rapid Low-Cost Tests Can Prevent Child Deaths from Contaminated Medicinal Syrups

Medicinal syrups contaminated with toxic chemicals have caused the deaths of hundreds of children worldwide, exposing a critical gap in how these products are tested before reaching patients.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.